NUSSDORF GLENN H 4
4 · Organogenesis Holdings Inc. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
NUSSDORF GLENN H
Director10% Owner
Transactions
- Sale
Class A Common Stock
2025-11-24$5.34/sh−100,000$534,000→ 2,965,591 total - Sale
Class A Common Stock
2025-11-25$5.30/sh−12,043$63,828→ 2,953,548 total - Sale
Class A Common Stock
2025-11-26$5.29/sh−187,957$994,293→ 2,765,591 total
Holdings
- 918,680(indirect: By Trust)
Class A Common Stock
- 7,928,570(indirect: By GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016)
Class A Common Stock
- 335,719(indirect: By Trust)
Class A Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.40, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.39, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.